Prostate cancer remains the most common in men. Researchers have discovered a way to find out if patients with Prostate cancer suffered (or not) from a fatal tumour. This work (source 1) was carried out by the Department of Medical Biosciences at the Swedish University of Umeå in collaboration with a research group at Uppsala University. The findings were published in the journal eBioMedicine.
“We discovered a new, previously unknown function of the TGF-β type I receptor (TbRI), which is a signaling protein important in cancer cells. Previous studies have shown that TGF-β signaling is important in the development of several forms of cancers,” explained Maréne Landström, professor of pathology at Umeå University. earlier men who are at risk of developing aggressive and potentially fatal prostate cancer.
A major discovery
Before completing: “But with the use of this new discovery, we can reassure men with prostate cancer whose prognosis is promising, and those with high-risk prostate cancer can be offered earlier treatment. Our findings and publication are important for a large group of prostate cancer patients, and there is reason to believe that other groups of patients will benefit.” In the future, this major discovery could also have other consequences for the treatment of other groups of cancer.